Related references
Note: Only part of the references are listed.Mutant p53 mediates survival of breast cancer cells
L. Y. Lim et al.
BRITISH JOURNAL OF CANCER (2009)
p53 isoforms - A conspiracy to kidnap p53 tumor suppressor activity?
V. Marcel et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
The Extracellular Matrix Regulates Cancer Progression and Therapy Response: Implications for Prognosis and Treatment
Hannelore Denys et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
p53 and little brother p53/47: linking IRES activities with protein functions
R. Grover et al.
ONCOGENE (2009)
Stress-dependent changes in the properties of p53 complexes by the alternative translation product p53/47
Darren J. Powell et al.
CELL CYCLE (2008)
Induction of genetic instability by gain-of-function p53 cancer mutants
Y. Xu
ONCOGENE (2008)
Mutant p53 R270H gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis
Christina Heinlein et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Crippling p53 activities via knock-in mutations in mouse models
T. Iwakuma et al.
ONCOGENE (2007)
p53 alterations in human cancer: more questions than answers
T. Soussi
ONCOGENE (2007)
Mutant p53: an oncogenic transcription factor
S. Strano et al.
ONCOGENE (2007)
Regulation of P53 stability in p53 mutated human and mouse hepatoma cells
Stephan Hailfinger et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Dissecting functional roles of p53 N-terminal transactivation domains by microarray expression analysis
Rieko Ohki et al.
CANCER SCIENCE (2007)
The oncogenic roles of p53 mutants in mouse models
Guillermina Lozano
CURRENT OPINION IN GENETICS & DEVELOPMENT (2007)
Expression of p53 and p53/47 are controlled by alternative mechanisms of messenger RNA translation initiation
M. M. Candeias et al.
ONCOGENE (2006)
Mice expressing a mammary gland-specific R270H mutation in the p53 tumor suppressor gene mimic human breast cancer development
SWP Wijnhoven et al.
CANCER RESEARCH (2005)
Nucleotide excision repair and p53-deficient mouse models in cancer research
EM Hoogervorst et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2005)
Lack of p53 Ser389 phosphorylation predisposes mice to develop 2-acetylaminofluorene-induced bladder tumors but not ionizing radiation-induced lymphomas
EM Hoogervorst et al.
CANCER RESEARCH (2005)
Modulation of mammalian life span by the short isoform of p53
B Maier et al.
GENES & DEVELOPMENT (2004)
Regulation of human p53 activity and cell localization by alternative splicing
A Ghosh et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
p53 Heterozygosity results in an increased 2-acetylaminofluorene-induced urinary bladder but not liver tumor response in DNA repair-deficient Xpa mice
EM Hoogervorst et al.
CANCER RESEARCH (2004)
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
KP Olive et al.
CELL (2004)
Increased sensitivity to UV radiation in mice with a p53 point mutation at Ser389
W Bruins et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Summaries of affymetrix GeneChip probe level data
RA Irizarry et al.
NUCLEIC ACIDS RESEARCH (2003)
Identifying biological themes within lists of genes with EASE
DA Hosack et al.
GENOME BIOLOGY (2003)
ΔN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53
S Courtois et al.
ONCOGENE (2002)
New insights into the role of extracellular matrix during tumor onset and progression
SM Pupa et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2002)
P53 stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products
YL Yin et al.
NATURE CELL BIOLOGY (2002)
Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function
A de Vries et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
